175 related articles for article (PubMed ID: 8380855)
1. Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8] neurotensin(8-13).
Donato di Paola E; Cusack B; Yamada M; Richelson E
J Pharmacol Exp Ther; 1993 Jan; 264(1):1-5. PubMed ID: 8380855
[TBL] [Abstract][Full Text] [Related]
2. Desensitization of neurotensin receptor-mediated cyclic GMP formation in neuroblastoma clone N1E-115.
Gilbert JA; Strobel TR; Richelson E
Biochem Pharmacol; 1988 Jul; 37(14):2833-8. PubMed ID: 2840079
[TBL] [Abstract][Full Text] [Related]
3. Role of signal transduction systems in neurotensin receptor down-regulation induced by agonist in murine neuroblastoma clone N1E-115 cells.
Yamada M; Yamada M; Richelson E
J Pharmacol Exp Ther; 1993 Oct; 267(1):128-33. PubMed ID: 8229740
[TBL] [Abstract][Full Text] [Related]
4. Further characterization of neurotensin receptor desensitization and down-regulation in clone N1E-115 neuroblastoma cells.
Yamada M; Yamada M; Richelson E
Biochem Pharmacol; 1993 May; 45(10):2149-54. PubMed ID: 8390262
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the neurotensin receptor and intracellular calcium mobilization in HT29 cells.
Turner JT; James-Kracke MR; Camden JM
J Pharmacol Exp Ther; 1990 Jun; 253(3):1049-56. PubMed ID: 2162944
[TBL] [Abstract][Full Text] [Related]
6. Regulation of [3H]phorbol-12,13-dibutyrate binding sites in mouse neuroblastoma cells: simultaneous down-regulation by phorbol esters and desensitization of their inhibition of muscarinic receptor function.
Lai WS; el-Fakahany EE
J Pharmacol Exp Ther; 1988 Jan; 244(1):41-50. PubMed ID: 3422096
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
[TBL] [Abstract][Full Text] [Related]
8. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
Law PY; Hom DS; Loh HH
Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
[TBL] [Abstract][Full Text] [Related]
9. LANT-6, xenopsin and neuromedin N stimulate cyclic GMP at neurotensin receptors.
Gilbert JA; Richelson E
Eur J Pharmacol; 1986 Oct; 129(3):379-83. PubMed ID: 3023108
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin and its analogs--correlation of specific binding with stimulation of cyclic GMP formation in neuroblastoma clone N1E-115.
Gilbert JA; Moses CJ; Pfenning MA; Richelson E
Biochem Pharmacol; 1986 Feb; 35(3):391-7. PubMed ID: 2868725
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin receptor down-regulation induced by dexamethasone and forskolin in rat hypothalamic cultures is mediated by endogenous neurotensin.
Scarcériaux V; Souazé F; Bachelet CM; Forgez P; Bourdel E; Martinez J; Rostène W; Pélaprat D
J Neuroendocrinol; 1996 Aug; 8(8):587-93. PubMed ID: 8866245
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin(8-13): comparison of novel analogs for stimulation of cyclic GMP formation in neuroblastoma clone N1E-115 and receptor binding to human brain and intact N1E-115 cells.
Gilbert JA; McCormick DJ; Pfenning MA; Kanba KS; Enloe LJ; Moore A; Richelson E
Biochem Pharmacol; 1989 Oct; 38(19):3377-82. PubMed ID: 2554923
[TBL] [Abstract][Full Text] [Related]
13. Characterization and autoradiographic localization of neurotensin binding sites in human sigmoid colon.
Azriel Y; Burcher E
J Pharmacol Exp Ther; 2001 Jun; 297(3):1074-81. PubMed ID: 11356931
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
[TBL] [Abstract][Full Text] [Related]
15. Binding and internalization of neurotensin in hybrid cells derived from septal cholinergic neurons.
Faure MP; Labbé-Jullié C; Cashman N; Kitabgi P; Beaudet A
Synapse; 1995 Jun; 20(2):106-16. PubMed ID: 7570339
[TBL] [Abstract][Full Text] [Related]
16. Developmental regulation of neurotensin receptor expression and function in murine neuroblastoma clone N1E-115.
Cusack B; Stanton T; Richelson E
Eur J Pharmacol; 1991 Apr; 206(4):339-42. PubMed ID: 1655492
[TBL] [Abstract][Full Text] [Related]
17. Rapid desensitization of dopamine release induced by neurotensin and neurotensin fragments.
Faggin BM; Cubeddu LX
J Pharmacol Exp Ther; 1990 May; 253(2):812-8. PubMed ID: 2338657
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C inhibitors alter neurotensin receptor binding and function in prostate cancer PC3 cells.
Carraway RE; Hassan S; Dobner PR
Regul Pept; 2008 Apr; 147(1-3):96-109. PubMed ID: 18313772
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the stimulation of inositol phospholipid hydrolysis and of cyclic GMP formation by neurotensin, some of its analogs, and neuromedin N in neuroblastoma clone N1E-115.
Kanba KS; Richelson E
Biochem Pharmacol; 1987 Mar; 36(6):869-74. PubMed ID: 3032199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
